Tags : Federico Trabaldo Togna

Corporate IP

Lenz & Staehelin advises Asceneuron on its agreement with Ferrer

Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron have announced the signing of a licensing agreement in which Ferrer obtains the exclusive worldwide rights to develop and commercialize ASN90 in progressive supranuclear palsy (PSP), an orphan neurological disease with a high unmet medical need. This agreement underscores the commitments both companies have […]

Deal & transactions

Lenz & Staehelin advises Gyrus in the sale of dss+

Inflexion and Gyrus Capital have announced that they have entered into an agreement for Inflexion to acquire a majority stake in dss+, a renowned provider of operations management consulting services with a purpose of saving lives and creating a sustainable future. Gyrus and dss+ management will retain a significant minority. The Inflexion investment is being made from […]

Corporate Deal & transactions

Lenz & Staehelin advises Unilabs in Proxilis acquisition

Unilabs, a leading diagnostic services provider, has announced it entered into a definitive agreement to acquire Proxilis, a diagnostics laboratory based in Geneva. The transaction closed in December 2022. The operator of test centres and laboratories has acquired the company Proxilis in Meyrin, specialised in medical analysis. The Proxilis laboratory will soon be renamed Unilabs. […]

Deal & transactions

Lenz & Staehelin and Bär & Karrer advise Gyrus Capital

The Swiss private equity operator Gyrus Capital has acquired the 40% of the Italian group Consulcesi, a renowned company focus in digital services dedicated to healthcare professionals and pharmaceutical companies. Gyrus Capital is a European investment company dedicated to digital transformation investments in the healthcare and sustainability sectors. Due to the expansion and strengthening of […]

Deal & transactions

Lenz & Staehelin advises Octium on the deal with Insurevolutions

The renowned provider of PPLI solutions Octium Group has agreed to acquire Insurevolution‘s PPLI business of approximately CHF 2.5 billion. This portfolio is primarily consisting of EU clients either in Liechtenstein or Ireland and will transfer to Octium Group’s Insurance Carriers in Liechtenstein and Ireland. The transfer is subject to regulatory approval and will see […]

Corporate Deal & transactions

Lenz & Staehelin advises Unilabs on its partnership with RIMED

Unilabs, a renowned diagnostic services provider, and RIMED, a recognised Swiss diagnostic radiology group, announced early November a unique partnership that will enable patients and referring facilities in Switzerland to benefit even more from integrated medical diagnostics. With the acquisition of a majority stake in RIMED, Unilabs strengthens its presence in German-speaking Switzerland and Ticino, […]

Deal & transactions

Lenz & Staehelin and Bär & Karrer in the sale

Forestay Capital, managed by Forestay Capital Management Limited, the closed-end tech fund launched in 2018 by B-FLEXION (previously Waypoint) and the management have sold their equity stake in BlueBotics, a navigation technology company based in St-Sulpice (VD), to Zapi group, an Italian manufacturer of electronic components for electric and hybrid vehicles. BlueBotics is a 2001 […]

Deal & transactions

Lenz & Staehelin: The shareholders of BlueBotics sell equity to

Forestay Capital, managed by Forestay Capital Management Limited, the closed-end tech fund launched in 2018 by B-FLEXION (previously Waypoint) and the management have sold their equity stake in BlueBotics, a navigation technology company based in St-Sulpice (VD), to Zapi group, an Italian manufacturer of electronic components for electric and hybrid vehicles.   BlueBotics is a 2001 […]